REVATIO Film-coated tablet Ref.[7092] Active ingredients: Sildenafil

Source: European Medicines Agency (EU)  Revision Year: 2018  Publisher: Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Product name and form

Revatio 20mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet.

White, round, biconvex film-coated tablets marked “PFIZER” on one side and “RVT 20” on the other.

Qualitative and quantitative composition

Each film-coated tablet contains 20mg of sildenafil (as citrate).

Excipient(s) with known effect: ach tablet also contains 0.7mg of lactose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Sildenafil

Sildenafil is a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5), the enzyme that is responsible for degradation of cGMP. Apart from the presence of this enzyme in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation.

List of Excipients

Tablet core:

Microcrystalline cellulose
Calcium hydrogen phosphate (anhydrous)
Croscarmellose sodium
Magnesium stearate

Film coat:

Hypromellose
Titanium dioxide (E171)
Lactose monohydrate
Glycerol triacetate

Pack sizes and marketing

PVC/Aluminium blisters of 90 tablets.

Pack size of 90 tablets in a carton.

90 × 1 tablets in PVC/Aluminium perforated unit dose blisters.

PVC/Aluminium blisters of 300 tablets.

Pack size of 300 tablets in a carton.

Not all pack sizes may be marketed.

Marketing authorization holder

Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Marketing authorization dates and numbers

EU/1/05/318/001
EU/1/05/318/004
EU/1/05/318/005

Date of first authorisation: 28 October 2005
Date of latest renewal: 23 September 2010

Drugs

Drug Countries
REVATIO Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.